169 related articles for article (PubMed ID: 16368469)
21. Postmenopausal hormone replacement therapy increases plasmatic thromboxane beta 2.
Oliveira RL; Aldrighi JM; Gebara OE; Rocha TR; D'Amico E; Rosano GM; Ramires JA
Int J Cardiol; 2005 Mar; 99(3):449-54. PubMed ID: 15771927
[TBL] [Abstract][Full Text] [Related]
22. Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17beta-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study.
Castelo-Branco C; Palacios S; Vázquez F; Villero J; Ferrer J; Ascaso C; Balasch J
Fertil Steril; 2007 Aug; 88(2):383-9. PubMed ID: 17561009
[TBL] [Abstract][Full Text] [Related]
23. Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients.
Nadar S; Blann AD; Lip GY
Am J Hypertens; 2006 Sep; 19(9):970-7; discussion 978. PubMed ID: 16942942
[TBL] [Abstract][Full Text] [Related]
24. The effects of pravastatin on hospital admission in hypercholesterolemic middle-aged men: West of Scotland Coronary Prevention Study.
J Am Coll Cardiol; 1999 Mar; 33(4):909-15. PubMed ID: 10091815
[TBL] [Abstract][Full Text] [Related]
25. The effect of postmenopausal hormone therapy with or without folic acid supplementation on serum homocysteine level.
Toprak A; Erenus M; Ilhan AH; Haklar G; Fak AS; Oktay A
Climacteric; 2005 Sep; 8(3):279-86. PubMed ID: 16390760
[TBL] [Abstract][Full Text] [Related]
26. Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system.
Eilertsen AL; Liestøl S; Mowinckel MC; Hemker HC; Sandset PM
Thromb Haemost; 2007 Jun; 97(6):938-43. PubMed ID: 17549295
[TBL] [Abstract][Full Text] [Related]
27. Effects of postmenopausal hormone replacement therapy on body fat composition.
Yüksel H; Odabasi AR; Demircan S; Köseoğlu K; Kizilkaya K; Onur E
Gynecol Endocrinol; 2007 Feb; 23(2):99-104. PubMed ID: 17454160
[TBL] [Abstract][Full Text] [Related]
28. Different effect induced by treatment with several statins on monocyte tissue factor expression in hypercholesterolemic subjects.
Bruni F; Puccetti L; Pasqui AL; Pastorelli M; Bova G; Cercignani M; Palazzuoli A; Leo A; Auteri A
Clin Exp Med; 2003 May; 3(1):45-53. PubMed ID: 12748879
[TBL] [Abstract][Full Text] [Related]
29. Effects of nebivolol on platelet activation in hypertensive patients: a comparative study with metoprolol.
Celik T; Yuksel UC; Iyisoy A; Kursaklioglu H; Ozcan O; Kilic S; Ozmen N; Isik E
Int J Cardiol; 2007 Mar; 116(2):206-11. PubMed ID: 16822563
[TBL] [Abstract][Full Text] [Related]
30. Combination of caregiving stress and hormone replacement therapy is associated with prolonged platelet activation to acute stress among postmenopausal women.
Aschbacher K; von Känel R; Mills PJ; Hong S; Roepke SK; Mausbach BT; Patterson TL; Ziegler MG; Dimsdale JE; Ancoli-Israel S; Grant I
Psychosom Med; 2007 Dec; 69(9):910-7. PubMed ID: 17991824
[TBL] [Abstract][Full Text] [Related]
31. A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1mg estradiol valerate/2mg dienogest on hot flushes in postmenopausal women.
Endrikat J; Graeser T; Mellinger U; Ertan K; Holz C
Maturitas; 2007 Oct; 58(2):201-7. PubMed ID: 17889463
[TBL] [Abstract][Full Text] [Related]
32. No effect of oral hormone replacement therapy on platelet function in postmenopausal women with coronary artery disease.
Håkan Wallén N; Li N; Eriksson-Berg M; Landgren BM; Schenck-Gustafsson K; Hjemdahl P
Thromb Haemost; 2006 Dec; 96(6):862-3. PubMed ID: 17139389
[No Abstract] [Full Text] [Related]
33. Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure.
Chung I; Choudhury A; Patel J; Lip GY
Ann Med; 2009; 41(1):45-51. PubMed ID: 18618353
[TBL] [Abstract][Full Text] [Related]
34. Effects of intranasal 17beta-estradiol and raloxifene on lipid profile and fibrinogen in hypercholesterolemic postmenopausal women: a randomized, placebo-controlled clinical trial.
Engin-Ustün Y; Ustün Y; Meydanli MM; Kafkasli A
Gynecol Endocrinol; 2006 Dec; 22(12):676-9. PubMed ID: 17162709
[TBL] [Abstract][Full Text] [Related]
35. Platelet activation status decreases after menopause.
Aldrighi JM; Oliveira RL; D'Amico E; Rocha T; Gebara OE; Rosano GM; Ramires JA
Gynecol Endocrinol; 2005 May; 20(5):249-57. PubMed ID: 16019369
[TBL] [Abstract][Full Text] [Related]
36. Hormone therapy affects plasma measures of factor VII-activating protease in younger postmenopausal women.
Sidelmann JJ; Skouby SO; Vitzthum F; Schwarz H; Jespersen J
Climacteric; 2010 Aug; 13(4):340-6. PubMed ID: 20222844
[TBL] [Abstract][Full Text] [Related]
37. Sleep deprivation and hormone therapy in postmenopausal women.
Kalleinen N; Polo O; Himanen SL; Joutsen A; Urrila AS; Polo-Kantola P
Sleep Med; 2006 Aug; 7(5):436-47. PubMed ID: 16815746
[TBL] [Abstract][Full Text] [Related]
38. Prevention of postmenopausal bone loss with long-cycle hormone replacement therapy.
Popp AW; Bodmer C; Senn C; Fuchs G; Kraenzlin ME; Wyss H; Birkhaeuser MH; Lippuner K
Maturitas; 2006 Jan; 53(2):191-200. PubMed ID: 16368472
[TBL] [Abstract][Full Text] [Related]
39. Effects of raloxifene and continuous combined hormone therapy on haemostasis variables: a multicenter, randomized, double-blind study.
Sgarabotto M; Baldini M; Dei Cas A; Manotti C; Luciana Barilli A; Rinaldi M; Benassi L; Bacchi Modena A
Thromb Res; 2007; 119(1):85-91. PubMed ID: 16499954
[TBL] [Abstract][Full Text] [Related]
40. Role of raloxifene on platelet metabolism and plasma lipids.
Nanetti L; Camilletti A; Francucci CM; Vignini A; Raffaelli F; Mazzanti L; Boscaro M
Eur J Clin Invest; 2008 Feb; 38(2):117-25. PubMed ID: 18226045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
